Atlas Trials

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Clinical trial NCT00736450 · TERMINATED

Trial details

NCT number
NCT00736450
Sponsor
University of Nebraska
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Large Cell LymphomaStage III Adult Diffuse Large Cell LymphomaStage IV Adult Diffuse Large Cell Lymphoma
Start date
2008-07-23
Primary completion
2012-10-09
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.